Home Tags Cancer: Prostate

Tag: Cancer: Prostate

Focal laser ablation of low- to intermediate-risk prostate cancer is associated with low morbidity and good oncologic outcomes

Morbidity Low With Focal Laser Ablation of Prostate Cancer

Tumor diameter above the median was only significant predictor for positive MRI after treatment
Prostate cancer incidence and mortality rates are decreasing or stabilizing in most countries

AACR: Prostate Cancer Incidence Dropping, Stable in Most Countries

Decreases in mortality seen in 14 countries, stabilization in 54 of 71 countries
Adding docetaxel-based chemotherapy to standard treatment for high-risk nonmetastatic prostate cancer improves survival

Docetaxel Chemo Ups Survival in High-Risk Localized Prostate Cancer

Findings based on addition of docetaxel chemotherapy to androgen suppression, radiotherapy
For patients with localized prostate cancer

Testosterone Replacement Slows Prostate Cancer Recurrence

Being on testosterone replacement slows time to biochemical recurrence in multivariable analysis
An individualized

Model Can Predict Survival in Nonmetastatic Prostate Cancer

Model demonstrated good discrimination for 15-year prostate cancer-specific mortality in validation cohorts
In men with low-risk and intermediate-risk prostate cancer

Stereotactic Body RT Promising for Low-, Intermediate-Risk PCa

Stereotactic body radiotherapy linked to low rates of severe toxic events, high rates of biochemical control
Low-dose aspirin use does not appear to reduce the overall risk for prostate cancer death

Low-Dose Aspirin Does Not Cut Death From Prostate Cancer

But during extended exposure periods of at least five years, low-dose aspirin may cut mortality
Metastasis-free survival is significantly longer among men with nonmetastatic

Darolutamide Slows Spread of Castration-Resistant Prostate Cancer

Significant survival benefit seen, adverse events similar between darolutamide and placebo
From 2010 to 2015

Use of Watchful Waiting Up for Low-Risk Localized Prostate Cancer

From 2010 to 2015, use of active surveillance/watchful waiting increased in low-risk disease
Finasteride is not associated with an increased risk for death due to prostate cancer

Finasteride Not Tied to Increase in Prostate Cancer Mortality

Finasteride tied to lower risk for death from prostate cancer, but lower risk not statistically significant